CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Bylaws or fiscal year change
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 4 Open-market sale Chief R&D Officer sold 10,712 shares at $0.67 ($7,177)
- 4 Open-market sale Chief Legal Officer sold 9,996 shares at $0.67 ($6,697)
- 4 Open-market sale President & CEO sold 23,208 shares at $0.67 ($15,549)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
Page 7 of 100 · 1,982 filings